Pentameric and Decameric Structures in Solution of Serum Amyloid P Component by X-ray and Neutron Scattering and Molecular Modelling Analyses

By Ashton A.W.   Boehm M.K.   Gallimore J.R.   Pepys M.B.   Perkins S.J.  

Journal of Molecular Biology, Vol. 272, Iss. 3, 1997-09 ,pp. : 408-422

Academic Press

Access to resources Recommend Favorite

The Structures of Crystalline Complexes of Human Serum Amyloid P Component with Its Carbohydrate Ligand, The Cyclic Pyruvate Acetal of Galactose

By Thompson D.   Pepys M.B.   Tickle I.   Wood S.  

Journal of Molecular Biology, Vol. 320, Iss. 5, 2002-07 ,pp. : 1081-1086

Academic Press

Access to resources Recommend Favorite

Mice Lacking Serum Amyloid P Component Do Not Necessarily Develop Severe Autoimmune Disease

By Soma M.   Tamaoki T.   Kawano H.   Ito S.   Sakamoto M.   Okada Y.   Ozaki Y.   Kanba S.   Hamada Y.   Ishihara T.   Maeda S.  

Biochemical and Biophysical Research Communications, Vol. 286, Iss. 1, 2001-08 ,pp. : 200-205

Elsevier

Access to resources Recommend Favorite

Serum Amyloid P Component Associates with High Density Lipoprotein as well as Very Low Density Lipoprotein but Not with Low Density Lipoprotein

By Li X.A.   Yutani C.   Shimokado K.  

Biochemical and Biophysical Research Communications, Vol. 244, Iss. 1, 1998-03 ,pp. : 249-252

Elsevier

Access to resources Recommend Favorite

Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate Inhibitor

By Rowsell S.   Hawtin P.   Minshull C.A.   Jepson H.   Brockbank S.M.V.   Barratt D.G.   Slater A.M.   McPheat W.L.   Waterson D.   Henney A.M.   Pauptit R.A.  

Journal of Molecular Biology, Vol. 319, Iss. 1, 2002-05 ,pp. : 173-181

Academic Press

Access to resources Recommend Favorite